Thrombotic Microangiopathy

Thrombotic Microangiopathy (TMA) is a serious condition affecting small blood vessels, leading to the formation of blood clots that can restrict blood flow. In the context of onconephrology, it often arises in patients with cancer, particularly those undergoing certain treatments like chemotherapy. TMA can cause kidney damage, resulting in symptoms such as high blood pressure, reduced kidney function, and swelling. Early detection and treatment are crucial to manage the condition and minimize kidney injury, making it important for healthcare providers to monitor patients, especially those with cancer and related therapies.